Sarcopenia, loss of muscle mass with age, is considered as a major cause of frailty and decreased independence in the elderly population. On the other hand, ageing is associated with an increase in prevalence of diabetes. In this review, we discuss the pathophysiological basis of sarcopenia and its relationship to oxidative stress and insulin resistance state, which contribute to development of glucose intolerance and type 2 diabetes. We will also discuss some ideas on the consequences and treatment of sarcopenia.
RosenbergI. Summary comments. Am J Clin Nutr1989;50:1231-33.
2.
HarrisT. Muscle mass and strength: relation to function in population studies. J Nutr1997;127:1004S-6S.
3.
BaumgartnerRNKoehlerKMGallagherD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol1998;147:755-63.
4.
JanssenIRossR. Linking age-related changes in skeletal muscle mass and composition with metabolism and disease. J Nutr Health Aging2005;9:408-19.
5.
KarakelidesHNairKS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol2005;68:123-48.
6.
JanssenI. Evolution of sarcopenia research. Appl Physiol Nutr Metab2010;35:707-12.
7.
Centers for Disease Control and Prevention. Crude and age-adjusted prevalence of diagnosed diabetes per 100 population, United States, 1980-2004 [online]. www.cdc.gov/diabetes/statistics/prev/national/figage.htm (Accessed July 2011).
8.
BlaumCSOfstedalMBLangaKMWrayLA. Functional status and health outcomes in older americans with diabetes mellitus. J Am Geriatr Soc2003;51:745-53.
9.
KimMJRollandYCepedaO. Diabetes mellitus in older men. Aging Male2006;9:139-47.
BaumgartnerRNWayneSJWatersDL. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res2004;12:1995-2004.
12.
PoderosoCConversoDPMalobertiP. A mitochondrial kinase complex is essential to mediate an ERK1/2-dependent phosphorylation of a key regulatory protein in steroid biosynthesis. PLoS One2008;3:e1443.
13.
KhodorovBPinelisVVergunO. Mitochondrial deenergization underlies neuronal calcium overload following a prolonged glutamate challenge. FEBS Lett1996;397:230-4.
14.
SarasteM. Oxidative phosphorylation at the fin de siecle. Science1999;283:1488-93.
15.
HerbstAPakJWMcKenzieD. Accumulation of mitochondrial DNA deletion mutations in aged muscle fibers: evidence for a causal role in muscle fiber loss. J Gerontol A Biol Sci Med Sci2007;62:235-45.
16.
JacksonMJ. Free radicals generated by contracting muscle: by-products of metabolism or key regulators of muscle function?Free Radic Biol Med2008;44:132-41.
17.
ConleyKEJubriasSAEsselmanPC. Oxidative capacity and ageing in human muscle. J Physiol2000;526(Part 1):203-10.
18.
CapelFRimbertVLiogerD. Due to reverse electron transfer, mitochondrial H2O2 release increases with age in human vastus lateralis muscle although oxidative capacity is preserved. Mech Ageing Dev2005;126:505-11.
19.
McKenzieDBuaEMcKiernanS. Mitochondrial DNA deletion mutations: a causal role in sarcopenia. Eur J Biochem2002;269: 2010-15.
20.
KoopmanRvan LoonLJ. Aging, exercise, and muscle protein metabolism. J Appl Physiol2009;106:2040-8.
21.
PetersenKFBefroyDDufourS. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science2003;300:1140-2.
22.
BradyMJSaltielAR. Closing in on the cause of insulin resistance and type 2 diabetes. J Clin Invest1999;104:675-6.
23.
Skov-JensenCSkovbroMFlintA. Contraction-mediated glucose uptake is increased in men with impaired glucose tolerance. Appl Physiol Nutr Metab2007;32:115-12.
24.
PowersSKKavazisANDeRuisseauKC. Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol2005;288:R337-44.
25.
CandowDGChilibeckPD. Effect of creatine supplementation during resistance training on muscle accretion in the elderly. J Nutr Health Aging2007;11:185-8.
26.
SchianoVBrevettiGSiricoG. Functional status measured by walking impairment questionnaire and cardiovascular risk prediction in peripheral arterial disease: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. Vasc Med2006;11:147-54.
27.
MorleyJE. Diabetes, sarcopenia, and frailty. Clin Geriatr Med2008;24:455-69.
28.
BrownWF. A method for estimating the number of motor units in thenar muscles and the changes in motor unit count with ageing. J Neurol Neurosurg Psychiatry1972;35:845-52.
29.
HakkinenKKallinenMLinnamoV. Neuromuscular adaptations during bilateral versus unilateral strength training in middle-aged and elderly men and women. Acta Physiol Scand1996;158:77-88.
30.
CaselliniCMVinikAI. Clinical manifestations and current treatment options for diabetic neuropathies. Endocr Pract2007;13:550-66.
31.
HarrisTBKielDRoubenoffR. Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: the Framingham Heart Study. J Am Geriatr Soc1997;45:133-9.
32.
RoubenoffRHughesVA. Sarcopenia: current concepts. J Gerontol A Biol Sci Med Sci2000;55:M716-24.
33.
GuttridgeDC. Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care2004;7: 443-50.
34.
Le RoithD. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med1997;336: 633-40.
35.
BenbassatCAMakiKCUntermanTG. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab1997;82:1484-91.
36.
CnopMHavelPJUtzschneiderKM. Relationship of adiponectin to body fat distribution, insulin sensitivityand plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia2003;46:459-69.
37.
YamauchiTKamonJMinokoshiY. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med2002;11:1288-95.
38.
ZoicoEDi FrancescoVMazzaliG. Adipocytokines, fat distribution, and insulin resistance in elderly men and women. J Gerontol A Biol Sci Med Sci2004;59:M935-9.
39.
RoubenoffRPariseHPayetteHA. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med2003; 115:429-35.
40.
HotamisligilG. Inflammatory pathways and insulin action. Int J Obes2003;27:S53-5.
41.
JensenG. Inflammation: roles in aging and sarcopenia. J Parenter Enteral Nutr2008;32:656-9.
42.
Ventura-ClapierRGarnierSVekslerV. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1α. Cardiovasc Res2008;79:208-17.
43.
PhillipsTLeeuwenburghC. Muscle fiber specific apoptosis and TNF-α signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J2005;19:668-70.
44.
FukagawaNKMinakerKLRoweJW. Glucose and amino acid metabolism in aging man: differential effects of insulin. Metabolism1988;37:371-7.
45.
WalshK. Adipokines, myokines and cardiovascular disease. Circ J2009;73:13-18.
46.
NaderGAEsserKA. Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. J Appl Physiol2001;90:1936-42.
47.
DohertyTJInvited review: aging and sarcopenia. J Appl Physiol2003;95:1717-27.
48.
Aubertin-LeheudreMLordCGouletED. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring)2006;14:2277-83.
49.
GoodpasterBHThaeteFLKelleyDE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr2000;71:885-92.
50.
BeasleyLEKosterANewmanAB. Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity (Silver Spring)2009;17:1062-9.
51.
MetterEJTalbotLASchragerMConwitR. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci2002;57:B359-65.
52.
RantanenTGuralnikJMFoleyD. Midlife hand grip strength as a predictor of old age disability. JAMA1999;281:558-60.
53.
PiersLSSoaresMJMcCormackLMO’DeaK. Is there evidence for an age-related reduction in metabolic rate?J Appl Physiol1998;85: 2196-204.
54.
FlegJLLakattaEG. Role of muscle loss in the age-associated reduction in VO2 max. J Appl Physiol1988;65:1147-51.
55.
AhmedNMandelRFainMJ. Frailty: an emerging geriatric syndrome. Am J Med2007;120:748-53.
WalstonJMcBurnieMANewmanA. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med2002;162:2333-41.
58.
FriedLPTangenCMWalstonJ. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci2001;56: M146-56.
59.
PowellC. Frailty: help or hindrance?J R Soc Med1997;90:23-6.
60.
RobertsonRGMontagniniM. Geriatric failure to thrive. Am Fam Physician2004;70:343-50.
61.
OstirGVOttenbacherKJMarkidesKS. Onset of frailty in older adults and the protective role of positive affect. Psychol Aging2004;19:402-08.
62.
BauerJMSieberCC. Sarcopenia and frailty: a clinician’s controversial point of view. Exp Gerontol2008;43:674-8.
63.
BinderEFSchechtmanKBEhsaniAA. Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial. J Am Geriatr Soc2002;50:1921-8.
64.
EvansWCampbellW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr1993;123(2 suppl):465-8.
65.
MorleyJEKimMJHarenMT. Frailty and hormones. Rev Endocr Metab Disord2005;6:101-08.
